Stock News

Deveron Corp. Announces Settlement of Promissory Note October 4, 2024 Toronto, Ontario–(Newsfile Corp. – October 4, 2024) – Deveron Corp. (TSXV: FARM) (“Deveron” or the “Company”), a leading agriculture services and data company in North America, is pleased to announce that further to its press releases of August 15, 2024 and September 16, 2024, the…

Spyre Therapeutics Announces Equity Inducement Awards WALTHAM, Mass. , Oct. 4, 2024 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently made an exciting announcement regarding equity inducement awards. The company is focused on utilizing innovative antibody engineering, therapeutic combinations, and precision medicine to enhance the treatment of Inflammatory Bowel Disease…

OnKure Therapeutics Announces Merger Completion and Milestones Achieved Advancing Precision Medicines in Oncology OnKure Therapeutics, a clinical-stage biopharmaceutical company based in Boulder, Colorado, is dedicated to advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), with an initial focus on breast cancer. The company recently announced the completion of its merger…

Cidara Therapeutics, Inc. Grants Stock Options and RSUs to New Employee New Employee Receives Stock Options and RSUs Cidara Therapeutics, Inc., a biotechnology company focused on developing drug-Fc conjugate immunotherapies, recently announced that the Compensation Committee of its Board of Directors has granted Dipesh Bhatt, a new employee, a non-qualified stock option award and restricted…

Aviat Networks Reports Strong Fourth Quarter Financial Results Overview Aviat Networks, Inc. recently announced its financial results for the fourth quarter of fiscal year 2024, ending on June 28, 2024. The company reported a total revenue of $116.7 million, which represents a significant 28.1% increase compared to the same quarter last year. Additionally, the company…

Ups and Downs: Altamira Therapeutics Ltd. Faces Nasdaq Listing Qualifications Issue What’s the Buzz in the Stock Market? Hamilton, Bermuda, Oct. 04, 2024 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO) recently made headlines when it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)…

Welcome Paul Rivett as the New CEO of Gold Reserve Ltd. An Exciting Announcement for Gold Reserve I am thrilled to share the news that Gold Reserve Ltd. has appointed Paul Rivett as its new Chief Executive Officer, effective immediately. Mr. Rivett, who has been serving as a Director and Executive Vice-Chairman of the board…

Let’s Talk Nokia: A Comedy of Share Buybacks So, picture this: it’s October 4, 2024, in Espoo, Finland. The Nokia Corporation is out here making moves, acquiring its own shares like it’s nobody’s business. I mean, who wouldn’t want to buy their own shares, right? It’s like treating yourself to a little gift, except instead…